View of JANUS KINASE ENZYME (JAK) INHIBITORS AND RHEUMATOID ARTHRITIS: A REVIEW OF THE LITERATURE | International Journal of Current Pharmaceutical Research
![Janus kinase (JAK) inhibitors block JAKs enzymatic activity activation.... | Download Scientific Diagram Janus kinase (JAK) inhibitors block JAKs enzymatic activity activation.... | Download Scientific Diagram](https://www.researchgate.net/publication/259270933/figure/fig1/AS:271065150652421@1441638376283/Janus-kinase-JAK-inhibitors-block-JAKs-enzymatic-activity-activation-Cytokines-or.png)
Janus kinase (JAK) inhibitors block JAKs enzymatic activity activation.... | Download Scientific Diagram
![JAK inhibition as a therapeutic strategy for immune and inflammatory diseases | Nature Reviews Drug Discovery JAK inhibition as a therapeutic strategy for immune and inflammatory diseases | Nature Reviews Drug Discovery](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrd.2017.201/MediaObjects/41573_2017_Article_BFnrd2017201_Fig1_HTML.jpg)
JAK inhibition as a therapeutic strategy for immune and inflammatory diseases | Nature Reviews Drug Discovery
![Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement | Annals of the Rheumatic Diseases Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/80/1/71/F1.large.jpg)
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement | Annals of the Rheumatic Diseases
![Frontiers | Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists Frontiers | Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists](https://www.frontiersin.org/files/Articles/437721/fphar-10-00212-HTML/image_m/fphar-10-00212-g001.jpg)
Frontiers | Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists
![JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib | Annals of the Rheumatic Diseases JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/80/7/865/F1.large.jpg)
JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib | Annals of the Rheumatic Diseases
![Pharmaceuticals | Free Full-Text | Janus Kinase Inhibitors and Coronavirus Disease (COVID)-19: Rationale, Clinical Evidence and Safety Issues Pharmaceuticals | Free Full-Text | Janus Kinase Inhibitors and Coronavirus Disease (COVID)-19: Rationale, Clinical Evidence and Safety Issues](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-14-00738/article_deploy/html/images/pharmaceuticals-14-00738-g001.png)
Pharmaceuticals | Free Full-Text | Janus Kinase Inhibitors and Coronavirus Disease (COVID)-19: Rationale, Clinical Evidence and Safety Issues
![JAK Inhibitors Are Coming and They Are the Biggest Eczema Development in Years | National Eczema Association JAK Inhibitors Are Coming and They Are the Biggest Eczema Development in Years | National Eczema Association](https://nationaleczema.org/wp-content/uploads/2021/01/JAK-Image-copy.png)
JAK Inhibitors Are Coming and They Are the Biggest Eczema Development in Years | National Eczema Association
![Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases - ScienceDirect Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1043661816307137-fx1.jpg)